Peapod Lane Capital LLC Kronos Bio, Inc. Transaction History
Peapod Lane Capital LLC
- $88.9 Billion
- Q1 2025
A detailed history of Peapod Lane Capital LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 564,572 shares of KRON stock, worth $395,200. This represents 0.52% of its overall portfolio holdings.
Number of Shares
564,572
Previous 562,620
0.35%
Holding current value
$395,200
Previous $534 Million
12.86%
% of portfolio
0.52%
Previous 0.53%
Shares
2 transactions
Others Institutions Holding KRON
# of Institutions
49Shares Held
19.4MCall Options Held
51.2KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$1.94 Million44.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.35 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.45MShares$1.01 Million0.02% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.01 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$997,5450.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $39.7M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...